Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Biophysical Journal
|
March 4, 2010
Two open states with progressive proton selectivities in the branched channelrhodopsin-2 photocycle
André Berndt, Matthias Prigge, Dietrich Gradmann, et al.
Biophysical Journal
|
September 6, 2011
Rectification of the channelrhodopsin early conductance
Dietrich Gradmann, André Berndt, Franziska Schneider, et al.
Journal of Molecular Biology
|
March 30, 2010
The branched photocycle of the slow-cycling channelrhodopsin-2 mutant C128T
Katja Stehfest, Eglof Ritter, André Berndt, et al.
Nature Neuroscience
|
December 17, 2008
Bi-stable neural state switches
André Berndt, Ofer Yizhar, Lisa A Gunaydin, et al.
Future Medicinal Chemistry
|
December 25, 2024
SETDB1: an emerging target for anticancer drug development
Gustavo Henrique Goulart Trossini, Haifa Hassanie, André Berndt Penteado, et al.
Nature Neuroscience
|
January 19, 2010
Ultrafast optogenetic control
Lisa A Gunaydin, Ofer Yizhar, André Berndt, et al.
Future Medicinal Chemistry
|
March 9, 2023
Human sirtuin 2 inhibitors, their mechanisms and binding modes
André Berndt Penteado, Haifa Hassanie, Renan Augusto Gomes, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 21, 2011
High-efficiency channelrhodopsins for fast neuronal stimulation at low light levels
André Berndt, Philipp Schoenenberger, Joanna Mattis, et al.
The Journal of Biological Chemistry
|
January 6, 2012
In channelrhodopsin-2 Glu-90 is crucial for ion selectivity and is deprotonated during the photocycle
Kirstin Eisenhauer, Jens Kuhne, Eglof Ritter, et al.
RSC Medicinal Chemistry
|
May 27, 2024
SETDB1 as a cancer target: challenges and perspectives in drug design
Haifa Hassanie, André Berndt Penteado, Larissa Costa de Almeida, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Biophysical Journal
|
March 4, 2010
Two open states with progressive proton selectivities in the branched channelrhodopsin-2 photocycle
André Berndt, Matthias Prigge, Dietrich Gradmann, et al.
Biophysical Journal
|
September 6, 2011
Rectification of the channelrhodopsin early conductance
Dietrich Gradmann, André Berndt, Franziska Schneider, et al.
Journal of Molecular Biology
|
March 30, 2010
The branched photocycle of the slow-cycling channelrhodopsin-2 mutant C128T
Katja Stehfest, Eglof Ritter, André Berndt, et al.
Nature Neuroscience
|
December 17, 2008
Bi-stable neural state switches
André Berndt, Ofer Yizhar, Lisa A Gunaydin, et al.
Future Medicinal Chemistry
|
December 25, 2024
SETDB1: an emerging target for anticancer drug development
Gustavo Henrique Goulart Trossini, Haifa Hassanie, André Berndt Penteado, et al.
Nature Neuroscience
|
January 19, 2010
Ultrafast optogenetic control
Lisa A Gunaydin, Ofer Yizhar, André Berndt, et al.
Future Medicinal Chemistry
|
March 9, 2023
Human sirtuin 2 inhibitors, their mechanisms and binding modes
André Berndt Penteado, Haifa Hassanie, Renan Augusto Gomes, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 21, 2011
High-efficiency channelrhodopsins for fast neuronal stimulation at low light levels
André Berndt, Philipp Schoenenberger, Joanna Mattis, et al.
The Journal of Biological Chemistry
|
January 6, 2012
In channelrhodopsin-2 Glu-90 is crucial for ion selectivity and is deprotonated during the photocycle
Kirstin Eisenhauer, Jens Kuhne, Eglof Ritter, et al.
RSC Medicinal Chemistry
|
May 27, 2024
SETDB1 as a cancer target: challenges and perspectives in drug design
Haifa Hassanie, André Berndt Penteado, Larissa Costa de Almeida, et al.
Page
of 2